Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences
- PMID: 10221344
- DOI: 10.1291/hypres.22.1
Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences
Abstract
Left ventricular (LV) size in childhood closely parallels body size, whereas in adulthood LV mass is increasingly affected by effects of obesity, hypertension, the level of cardiac volume load, and the level of LV myocardial contractility. Recently, additional independent associations of diabetes, arterial structure and function and as yet unknown genes with higher LV mass have been defined; angiotensin II and insulin have also been suggested to be additive stimuli to LV hypertrophy. Consideration of the level of LV mass and of the LV wall thickness/chamber radius ratio (relative wall thickness) has identified four different geometric patterns of LV adaptation to hypertension, including concentric LV hypertrophy (increased mass and wall thickness), eccentric hypertrophy (increased mass, normal relative wall thickness), concentric remodeling (increased relative wall thickness with normal mass) and normal LV geometry. Concentric hypertrophy is associated with especially high arterial pressure while eccentric hypertrophy is associated with obesity and elevated volume load. Numerous studies show that increased LV mass predicts cardiovascular events and death independently of all conventional risk factors; initial studies have also identified adverse implications of low LV midwall function and high relative wall thickness. Pioneer studies strongly suggest that reversal of LV hypertrophy is associated with an improved prognosis.
Similar articles
-
Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.Am Heart J. 2001 May;141(5):784-91. doi: 10.1067/mhj.2001.114803. Am Heart J. 2001. PMID: 11320367 Clinical Trial.
-
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy.Am J Cardiol. 1996 Jul 15;78(2):197-202. doi: 10.1016/s0002-9149(96)90395-1. Am J Cardiol. 1996. PMID: 8712142
-
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.Am J Cardiol. 2001 Jan 1;87(1):54-60. doi: 10.1016/s0002-9149(00)01272-8. Am J Cardiol. 2001. PMID: 11137834
-
Myocardial remodeling in hypertension.J Hum Hypertens. 2015 Jan;29(1):1-6. doi: 10.1038/jhh.2014.36. Epub 2014 May 8. J Hum Hypertens. 2015. PMID: 24804791 Review.
-
Left ventricular hypertrophy and hypertension.Clin Exp Hypertens. 1993 Nov;15(6):1025-32. doi: 10.3109/10641969309037090. Clin Exp Hypertens. 1993. PMID: 8268870 Review.
Cited by
-
The application of vWF/ADAMTS13 in essential hypertension.Int J Clin Exp Med. 2014 Dec 15;7(12):5636-42. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25664083 Free PMC article.
-
Association of glycemic status and segmental left ventricular wall thickness in subjects without prior cardiovascular disease: a cross-sectional study.BMC Cardiovasc Disord. 2018 Aug 9;18(1):162. doi: 10.1186/s12872-018-0900-7. BMC Cardiovasc Disord. 2018. PMID: 30092757 Free PMC article.
-
Leveraging Preexisting Cardiovascular Data to Improve the Detection and Treatment of Hypertension: The NOTIFY-LVH Randomized Clinical Trial.JAMA Cardiol. 2025 Jul 1;10(7):686-695. doi: 10.1001/jamacardio.2025.0871. JAMA Cardiol. 2025. PMID: 40162953 Clinical Trial.
-
The Correlation Between ABPM Parameters and Left Ventricular Hypertrophy in Pediatric Essential Hypertension.Front Pediatr. 2022 Jun 2;10:896054. doi: 10.3389/fped.2022.896054. eCollection 2022. Front Pediatr. 2022. PMID: 35722487 Free PMC article.
-
Diabetic cardiomyopathy: bench to bedside.Heart Fail Clin. 2012 Oct;8(4):619-31. doi: 10.1016/j.hfc.2012.06.007. Epub 2012 Aug 9. Heart Fail Clin. 2012. PMID: 22999244 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical